• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Sanofi wins appeal in spat with NICE over Sarclisa

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 13, 2024 at 11:02: AM
via Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a treatment for relapsed and refractory multiple myeloma (RRMM).

article source
 




Top Bottom
Back
Quote